Oh my. Now another American desiccated thyroid (NDT) brand recall? Earlier this year, Acella's NP thyroid was found to be superpotent (over 110% on the T3 content), and they issued a voluntary recall. Now, as of August 25, 2020, Nature-Throid and/or WP-Thyroid are sub-potent, so their manufacturer RLC Labs is issuing a voluntary recall. QUOTE: … Continue reading RLC Labs issues Nature-Throid and WP-thyroid recall for subpotency
Acella, the makers of NP Thyroid, issued a voluntary recall notice on May 22, 2020. This is part 2 of a two-part series reviewing the drug recall notice's statements and the science behind them. [Part 1: Acella NP Thyroid recall: Ethical yet low-risk] We should applaud Acella for being so conscientious about the exact amounts … Continue reading Acella NP Thyroid recall: maternal risk inflated
Acella, the makers of NP Thyroid, issued a voluntary recall notice on May 22, 2020. This is part 1 of a two-part series reviewing the drug recall notice's statements and the science behind them. In this post, I put this recall in the context of pharmaceutical guidelines and manufacturing challenges. I also portray the variable … Continue reading Acella NP Thyroid recall: Ethical yet low-risk
In this Part 3, I continue my rebuttal of a research article that blames thyroid patients for causing harm to themselves by making requests of doctors for tests and therapies. In this post, I explain the good signs that thyroid patients' self-advocacy is sometimes effective and is making a difference.
Some members of the American Thyroid Association (ATA) have achieved a new ethical low. The ATA have published in their official scientific journal, Thyroid, an article by Esfandiari and colleagues (2019) that blames thyroid patients for causing harm to themselves by making requests of doctors for tests and therapies. They titled their paper "Patient Requests … Continue reading 2019 ATA article engages in patient-blaming and doctor-shaming
